Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight concerns about the weak scientific evidence for many claims about psychedelics, citing the need for rigorous research and caution, as seen in phrases like 'lack of solid evidence' and 'prioritize public health.' Users also demonstrate interest through mentions of regulatory decisions and ongoing debates, using tones that range from skeptical to cautiously optimistic, which collectively suggests a moderate level of engagement with potential implications of the publication.
Most discussions agree that current evidence supporting psychedelic therapy is weak and caution is necessary, reflecting shared skepticism.
The discussions show high interest, with multiple mentions of upcoming research, FDA decisions, and calls for rigorous studies.
There is moderate engagement, with some users emphasizing policy implications and criticizing biases, indicating thoughtful consideration rather than superficial commentaries.
While impactful on public health policy and research directions, the discussions mainly serve to inform rather than directly influence widespread change yet.
Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big money" is up at Annual Review of Psychology. Abstract below. https://t.co/eecqbPRoUO https://t.co/TlhyCGAqTm
Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money https://t.co/4fDhqA8vYv
Psychedelic drugs are surging in popular culture as a treatment for mental afflictions, but the therapeutic claims about many of these drugs have not been evaluated in any studies of even modest rigor, cautions @KeithNHumphreys.
Published a week before the FDA's decision on @Lykos #MDMA drug: https://t.co/9P8P8ImSxn Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money @KeithNHumphreys et. al. See our current issue for full story.
Until more research is done to evaluate the therapeutic potential and mechanisms of psychedelic drugs, policies governing their use must prioritize the protection of public health over industry profit motives, says @KeithNHumphreys.
Rigorous research — not profit motives or popular interest — should be the driving force behind evaluating the therapeutic potential and mechanisms of psychedelic drugs, says @KeithNHumphreys.
This video explores the health benefits of Blue Zones, the risks of Ozempic, and the impact of nutrition, fasting, and psychedelics on longevity and wellness. It highlights how lifestyle choices influence a longer…
Is milk really healthy? What are the risks of Ozempic? In this video, we investigate these questions and explore longevity lessons from Blue Zones. Learn how nutrition, fasting, and psychedelics may revolutionize your…
January 2025 Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money https://t.co/gBHOlkwVLn 3 Mar 2025 Psychedelic drug studies face a potent source of bias: the ‘trip’ https://t.co/yyNhNpqQSg .
Rigorous research — not profit motives or popular interest — should be the driving force behind evaluating the therapeutic potential and mechanisms of psychedelic drugs, says @KeithNHumphreys.
Until more research is done to evaluate the therapeutic potential and mechanisms of psychedelic drugs, policies governing their use must prioritize the protection of public health over industry profit motives, says @KeithNHumphreys.
Psychedelic drugs are surging in popular culture as a treatment for mental afflictions, but the therapeutic claims about many of these drugs have not been evaluated in any studies of even modest rigor, cautions @KeithNHumphreys.
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
Published a week before the FDA's decision on @Lykos #MDMA drug: https://t.co/9P8P8ImSxn Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money @KeithNHumphreys et. al. See our current issue for full story.
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
RT @KeithNHumphreys: Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big m…
Our review "Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big money" is up at Annual Review of Psychology. Abstract below. https://t.co/eecqbPRoUO https://t.co/TlhyCGAqTm
RT @bertogliolab: Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money https://t.…
Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money https://t.co/4fDhqA8vYv
Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money https://t.co/Z05yFzCtBa https://t.co/heAdQHB0BL